Krishna Institute of Medical Sciences Limited · NSE: KIMS · BSE: 543308
Krishna Institute of Medical Sciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 03 Aug 2026.
Q1 FY27 · Consolidated
Revenue
1,179.50₹ Cr
+35.3% vs year ago
Net profit
37.40₹ Cr
−56.0% vs year ago
EPS, basic
1.04₹
−46.9% vs year ago
Net margin
3.2%
−6.6 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 1,179.50 | +35.3% | 37.40 | −56.0% | 1.04 | 03 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 1,074.60 | +34.8% | 33.10 | −68.8% | 1.06 | 15 May 2026 |
| Q3 FY26Oct–Dec 2025 | 997.70 | +29.2% | 51.90 | −43.9% | 1.33 | 06 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 960.70 | +23.6% | 72.00 | −40.3% | 1.67 | 07 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 871.60 | +26.6% | 85.00 | −10.7% | 1.96 | 06 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 796.90 | +25.7% | 106.10 | +48.4% | 2.54 | 12 May 2025 |
| Q3 FY25Oct–Dec 2024 | 772.40 | +27.5% | 92.50 | +20.8% | 2.22 | 06 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 777.30 | +19.1% | 120.70 | +19.2% | 2.68 | 09 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 688.40 | +13.6% | 95.20 | +9.8% | 10.82 | 08 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 633.80 | +10.0% | 71.49 | −27.5% | 8.18 | 18 May 2024 |
| Q3 FY24Oct–Dec 2023 | 605.84 | +7.8% | 76.55 | −6.4% | 8.98 | 05 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 652.48 | +15.7% | 101.29 | −4.5% | 11.50 | 09 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 606.03 | +22.3% | 86.67 | +9.4% | 10.10 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 575.93 | +54.7% | 98.67 | +18.4% | 11.65 | 19 May 2023 |
| Q3 FY23Oct–Dec 2022 | 562.16 | +42.8% | 81.83 | −2.8% | 9.49 | 10 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 564.07 | +37.0% | 106.07 | +25.9% | 12.14 | 13 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 495.51 | +4.7% | 79.25 | −13.9% | 8.74 | 12 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 372.34 | — | 83.32 | — | 10.08 | 24 May 2022 |
| Q3 FY22Oct–Dec 2021 | 393.57 | — | 84.19 | — | 10.14 | 10 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 411.74 | — | 84.25 | — | 10.34 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 473.18 | — | 92.03 | — | 11.48 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 0.00 | — | 0.00 | — | 0.00 | 09 Jul 2021 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 483.60 | +29.5% | 66.50 | +13.1% | 1.66 | 03 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 456.20 | +31.9% | 65.90 | −29.6% | 1.65 | 15 May 2026 |
| Q3 FY26Oct–Dec 2025 | 441.90 | +27.2% | 72.50 | −5.2% | 1.81 | 06 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 430.00 | +18.4% | 63.50 | −12.0% | 1.59 | 07 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 373.40 | +14.1% | 58.80 | −3.1% | 1.47 | 06 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 345.90 | +13.5% | 93.60 | +94.2% | 2.34 | 12 May 2025 |
| Q3 FY25Oct–Dec 2024 | 347.50 | +15.0% | 76.50 | +31.1% | 1.91 | 06 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 363.30 | +14.9% | 72.20 | +9.1% | 1.80 | 09 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 327.40 | +9.5% | 60.70 | −3.1% | 7.58 | 08 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 304.85 | +3.9% | 48.19 | −35.5% | 6.02 | 18 May 2024 |
| Q3 FY24Oct–Dec 2023 | 302.06 | +6.5% | 58.35 | −9.5% | 7.29 | 05 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 316.25 | +8.2% | 66.16 | +8.1% | 8.27 | 09 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 298.90 | +13.7% | 62.63 | +20.2% | 7.83 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 293.35 | +15.3% | 74.70 | +16.9% | 9.33 | 19 May 2023 |
| Q3 FY23Oct–Dec 2022 | 283.51 | +3.8% | 64.47 | −3.8% | 8.06 | 10 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 292.21 | +2.8% | 61.20 | −14.2% | 7.65 | 13 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 262.95 | −20.7% | 52.12 | −31.6% | 6.51 | 12 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 254.50 | — | 63.91 | — | 7.99 | 24 May 2022 |
| Q3 FY22Oct–Dec 2021 | 273.19 | — | 66.99 | — | 8.37 | 10 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 284.17 | — | 71.31 | — | 8.91 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 331.51 | — | 76.16 | — | 9.81 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 0.00 | — | 0.00 | — | 0.00 | 09 Jul 2021 |
44 filings on record for this company.